Efficacy and Safety of Nitrazine in the Treatment of ALS

Clinical trial NCT04950647 · UNKNOWN

Trial details

NCT number: NCT04950647
Sponsor: Peking University Third Hospital
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Amyotrophic Lateral Sclerosis

Start date: 2020-07-01
Primary completion: 2022-07-31
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.